Deep Track Capital, LP Portfolio Holdings

Deep Track Capital, LP

  • $3.17 Billion
  • Q3 2025

Deep Track Capital, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $3.17 Billion distributed in 56 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Immunovant, Inc. with a value of $268M, Guardant Health, Inc. with a value of $260M, Ionis Pharmaceuticals Inc with a value of $249M, Cytokinetics Inc with a value of $236M, and Akero Therapeutics, Inc. with a value of $190M.

Examining the 13F form we can see an increase of $350M in the current position value, from $2.82B to 3.17B.

Deep Track Capital, LP is based out at Greenwich, CT

Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $3.17 Billion
Healthcare: $3.17 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.55B
$268 Million 8.45% of portfolio
9,728,845
Q3 2025 Added 2.41%
$9.65B
$260 Million 8.19% of portfolio
4,154,086
Q3 2025 Reduced 2.26%
$10.2B
$249 Million 7.86% of portfolio
3,808,144
Q3 2025 Reduced 22.15%
$6.25B
$236 Million 7.46% of portfolio
4,300,000
Q3 2025 Added 17.81%
$2.52B
$190 Million 5.99% of portfolio
4,000,978
Q3 2025 Added 31.5%
$2.23B
$181 Million 5.71% of portfolio
8,000,382
Q3 2025 Added 14.29%
$1.92B
$178 Million 5.63% of portfolio
3,000,000
Q3 2025 Added 71.43%
$1.4B
$156 Million 4.93% of portfolio
15,726,349
Q3 2025 Reduced 11.61%
$875M
$139 Million 4.4% of portfolio
11,932,137
Q3 2025 Reduced 16.53%
$690M
$137 Million 4.33% of portfolio
9,356,171
Q3 2025 Reduced 1.51%
$1.15B
$116 Million 3.65% of portfolio
5,380,449
Q1 2025 Added 18.96%
$4.15B
$114 Million 3.6% of portfolio
1,715,691
Q3 2025 Reduced 47.14%
$5.99B
$109 Million 3.45% of portfolio
900,000
Q3 2025 Added 12.31%
$2.87B
$108 Million 3.41% of portfolio
3,000,000
Q3 2025 Added 39.53%
$363M
$67.1 Million 2.12% of portfolio
7,859,648
Q3 2025 Reduced 11.0%
$1.58B
$65.4 Million 2.06% of portfolio
1,800,000
Q2 2025 Added 27.53%
$846M
$57 Million 1.8% of portfolio
7,495,000
Q2 2025 Added 34.4%
$423M
$56.3 Million 1.78% of portfolio
41,096,522
Q3 2025 Reduced 4.43%
$603M
$56 Million 1.77% of portfolio
6,057,024
Q3 2025 Reduced 0.13%
$11.9B
$54.7 Million 1.73% of portfolio
1,000,000
Q3 2025 New
$1.2B
$51.7 Million 1.63% of portfolio
2,000,000
Q1 2025 Added 29.86%
$2.54B
$48.2 Million 1.52% of portfolio
1,200,000
Q3 2025 Reduced 11.11%
$1.46B
$41.2 Million 1.3% of portfolio
450,000
Q3 2025 Reduced 35.71%
$351M
$33.5 Million 1.06% of portfolio
3,470,172
Q3 2025 Added 0.79%
$1.4B
$28.2 Million 0.89% of portfolio
483,092
Q3 2025 New
$975M
$25.3 Million 0.8% of portfolio
2,000,000
Q3 2025 New
$728M
$17.9 Million 0.56% of portfolio
1,250,000
Q3 2025 Reduced 37.5%
$19.9B
$14.8 Million 0.47% of portfolio
481,267
Q3 2025 New
$720M
$12.2 Million 0.39% of portfolio
1,454,562
Q3 2025 New
$18.5M
$7.2 Million 0.23% of portfolio
7,419,355
Q2 2024 New
$891M
$6.44 Million 0.2% of portfolio
549,439
Q1 2025 Added 9.89%
$467M
$5.99 Million 0.19% of portfolio
500,000
Q3 2025 New
$112M
$5.54 Million 0.17% of portfolio
1,200,000
Q3 2025 New
$126M
$4.21 Million 0.13% of portfolio
2,568,613
Q3 2025 Reduced 84.76%
$3.89B
$2.24 Million 0.07% of portfolio
105,085
Q3 2025 New
$109M
$2.1 Million 0.07% of portfolio
509,789
Q3 2025 Reduced 50.99%
$10.2B
$1.35 Million 0.04% of portfolio
24,856
Q3 2025 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 74.5%
Oruka Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 38.36%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 20.0%
Maze Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 20.79%
Bicara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 21.33%
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 81.93%
X4 Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Crescent Biopharma Inc.
-
$0 0.0% of portfolio
-
Q2 2025 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 17.88%
Mbx Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 43.93%
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 40.0%
Lb Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 56
  • Current Value $3.17 Billion
  • Prior Value $2.82 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 12 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email